PATENT CLAIM ANALYSIS

Application Number: 16057586
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "496000"]

Abstract:
The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT 1A  receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1) wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.

Claim (Index 10):
The method of  claim 9 , wherein the disorder is bipolar I disorder as defined in (i).

Metadata:
- Claim Count in Document: 15.0
- Percentile: 96.0
- Lexical Diversity: 1.24528
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11932795', '10055915', '13327607', '13195954', '12202201']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7656467468311777
- 35 USC 102 Novelty (BERT): 0.5438029344001382
- Combined Prediction Score: 0.7434623655880738
- Mean Citation Score: 479.800086
- Max Citation Score: 482.2739
- Similarity Product: 177.6085230107427

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test